Lidia Sánchez-Moral

447 total citations
7 papers, 251 citations indexed

About

Lidia Sánchez-Moral is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Lidia Sánchez-Moral has authored 7 papers receiving a total of 251 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 5 papers in Immunology and 2 papers in Molecular Biology. Recurrent topics in Lidia Sánchez-Moral's work include Immunotherapy and Immune Responses (4 papers), Immune cells in cancer (3 papers) and Cancer Immunotherapy and Biomarkers (2 papers). Lidia Sánchez-Moral is often cited by papers focused on Immunotherapy and Immune Responses (4 papers), Immune cells in cancer (3 papers) and Cancer Immunotherapy and Biomarkers (2 papers). Lidia Sánchez-Moral collaborates with scholars based in Spain, United States and Hungary. Lidia Sánchez-Moral's co-authors include María Jesús Fernández‐Aceñero, Oriol de Barrios, Antonio Postigo, Douglas S. Darling, Balázs Győrffy, Douglas C. Dean, Marlies Cortés, Anna Esteve‐Codina, Toby Lawrence and Maria‐Rosa Sarrias and has published in prestigious journals such as The EMBO Journal, Gut and International Journal of Molecular Sciences.

In The Last Decade

Lidia Sánchez-Moral

6 papers receiving 247 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lidia Sánchez-Moral Spain 6 125 104 80 72 34 7 251
Xiaoli Xie China 9 188 1.5× 106 1.0× 81 1.0× 58 0.8× 26 0.8× 19 329
Benjamin T. Dake United States 6 218 1.7× 71 0.7× 69 0.9× 53 0.7× 48 1.4× 7 355
Shaoxian Wu China 10 137 1.1× 148 1.4× 115 1.4× 60 0.8× 21 0.6× 27 294
Kuiran Liu China 9 149 1.2× 53 0.5× 44 0.6× 116 1.6× 28 0.8× 11 284
Yimin Lao China 9 247 2.0× 85 0.8× 67 0.8× 63 0.9× 33 1.0× 11 324
Xiaozhang Xu China 4 181 1.4× 119 1.1× 61 0.8× 162 2.3× 29 0.9× 7 331
Xingli Zhang China 8 262 2.1× 127 1.2× 50 0.6× 124 1.7× 32 0.9× 19 399
Junyi Yin China 7 147 1.2× 58 0.6× 50 0.6× 90 1.3× 28 0.8× 8 254
Hongjiu Ren China 13 240 1.9× 80 0.8× 79 1.0× 134 1.9× 41 1.2× 18 355

Countries citing papers authored by Lidia Sánchez-Moral

Since Specialization
Citations

This map shows the geographic impact of Lidia Sánchez-Moral's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lidia Sánchez-Moral with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lidia Sánchez-Moral more than expected).

Fields of papers citing papers by Lidia Sánchez-Moral

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lidia Sánchez-Moral. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lidia Sánchez-Moral. The network helps show where Lidia Sánchez-Moral may publish in the future.

Co-authorship network of co-authors of Lidia Sánchez-Moral

This figure shows the co-authorship network connecting the top 25 collaborators of Lidia Sánchez-Moral. A scholar is included among the top collaborators of Lidia Sánchez-Moral based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lidia Sánchez-Moral. Lidia Sánchez-Moral is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Sisó, Pol, Óscar Maiques, Núria Eritja, et al.. (2025). High Copy Number Variations Correlate with a Pro-Tumoral Microenvironment and Worse Prognosis in Acral Lentiginous Melanoma. International Journal of Molecular Sciences. 26(9). 4097–4097.
2.
Sànchez‐Tilló, Ester, Leire Pedrosa, Balázs Győrffy, et al.. (2023). The EMT factor ZEB1 paradoxically inhibits EMT in BRAF-mutant carcinomas. JCI Insight. 8(20). 7 indexed citations
3.
Sánchez-Moral, Lidia, et al.. (2022). Macrophages as a Therapeutic Target in Metastatic Prostate Cancer: A Way to Overcome Immunotherapy Resistance?. Cancers. 14(2). 440–440. 29 indexed citations
4.
Sánchez-Moral, Lidia, et al.. (2021). Multifaceted Roles of CD5L in Infectious and Sterile Inflammation. International Journal of Molecular Sciences. 22(8). 4076–4076. 27 indexed citations
5.
Barrios, Oriol de, Lidia Sánchez-Moral, Marlies Cortés, et al.. (2019). ZEB1 promotes inflammation and progression towards inflammation-driven carcinoma through repression of the DNA repair glycosylase MPG in epithelial cells. Gut. 68(12). 2129–2141. 42 indexed citations
6.
Cortés, Marlies, Lidia Sánchez-Moral, Oriol de Barrios, et al.. (2017). Tumor‐associated macrophages (TAMs) depend on ZEB1 for their cancer‐promoting roles. The EMBO Journal. 36(22). 3336–3355. 114 indexed citations
7.
Barrios, Oriol de, Balázs Győrffy, María Jesús Fernández‐Aceñero, et al.. (2016). ZEB1-induced tumourigenesis requires senescence inhibition via activation of DKK1/mutant p53/Mdm2/CtBP and repression of macroH2A1. Gut. 66(4). 666–682. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026